MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
$11,896K
Accounts payable
$1,156K
Purchases of machinery and
equipment
-$86K
Operating lease right of
use liability
$743K
Accrued expenses and
other current...
$727K
Net cash used in
operating activities
$12,133K
Net cash used in
investing activities
$86K
Canceled cashflow
$2,389K
Net increase in cash
and restricted cash
$246K
Canceled cashflow
$11,973K
Stock-based compensation
-$1,427K
Depreciation and
amortization expense
-$802K
Change in fair value of
other liabilities and...
-$132K
Prepaid expenses and
other current assets
$28K
Proceeds from public
offerings
$5,369K
Payment of financing
costs
-$554K
Repayment of financing
lease obligations
-$19K
Net cash provided by
financing activities
-$11,960K
Effect of exchange rate
changes on cash
-$13K
Canceled cashflow
$5,942K
something is missing
-$17,902K
Back
Back
Cash Flow
Calidi Biotherapeutics, Inc. (CLDI)
Calidi Biotherapeutics, Inc. (CLDI)
source: myfinsight.com